Genetic and proteomic approaches to identify cancer drug targets

Area of Science:

• Drug discovery and development
• Cancer biology
• Molecular biology

Background:

• Traditional target-based small-molecule discovery faces limitations with certain cancer-promoting proteins.
• Phenotypic screening approaches, including gene expression-based and high-content imaging, offer alternatives for identifying modulators of biological states without prior target knowledge.
• A significant challenge in phenotypic screening is identifying the specific protein targets of active small molecules.

Purpose of the Study:

• To review emerging technologies and approaches for protein target identification in drug discovery.
• To discuss the application of genomic, genetic, and proteomic strategies for identifying small-molecule targets.
• To highlight advancements that address the challenge of target deconvolution in phenotypic screening.

Main Methods:

• Genomic approaches: Gene expression-based screening.
• Genetic approaches: Short hairpin RNA (shRNA) screening and open reading frame (ORF) screening.
• Proteomic approaches: Utilizing proteomic techniques for target identification.

Main Results:

• The review synthesizes current knowledge on various methods for protein target identification.
• It highlights the potential of emerging technologies to streamline the target identification process.
• The discussion covers the practical application of different screening modalities.

Conclusions:

• Genomic, genetic, and proteomic approaches are crucial for identifying protein targets of small molecules identified via phenotypic screening.
• Advancements in these areas are vital for overcoming limitations in traditional drug discovery and addressing challenging targets.
• Effective target identification strategies are essential for the successful translation of phenotypic screening into novel therapeutics.